Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 269-412-8 | CAS number: 68238-92-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
The substance is expected to be non-mutagenic in Salmonella typhimurium reverse mutation assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From September 13 to November 10, 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Justification for type of information:
- The read across approach is detailed into the document attached to the IUCLID section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted July 21,1997
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: bacterial strains TA 1535, TA 98, TA 100, and TA 102 were obtained from Dr. B.N. Ames (University of California, 94720 Berkeley, U.S.A.). The bacterial strain TA 1537 was obtained from BASF (D-67063 Ludwigshafen),
PERIODICAL CHECK
Regular checking of the properties of the strains regarding the membrane permeability and ampicillin resistance as well as spontaneous mutation rates is performed in testing facility.
PRECULTURES
From the thawed ampoules of the strains 0.5 ml bacterial suspension were transferred into 250 ml Erlenmeyer flasks containing 20 ml nutrient medium. A solution of 20 µl ampicillin (25 µg/ml) was added to the strains TA 98, TA 100, and TA 102.20 µl tetracycline (2 µg/ml) was added to strain TA 102. This nutrient medium contains per litre.
8 g Merck Nutrient Broth
5 g NaCl
The bacterial culture was incubated in a shaking water bath for 8 hours at 37 °C. - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 liver microsomal fraction
- Test concentrations with justification for top dose:
- 33, 100, 333, 1000, 2500 and 5000 µg/plate
- Vehicle / solvent:
- - Vehicle: on the day of experiment, the test item was dissolved in deionised water.
- Justification for choice of solvent/vehicle: the solvent was chosen to its solubility properties. - Untreated negative controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- congo red
- methylmethanesulfonate
- other: 4-Nitro-o-phenylene-diamine // 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation. According to the pre-incubation method 100 µl test solution, 500 µl S9 mix / S9 mix substitution buffer, and 100 µl bacteria suspension were mixed in a test tube and incubated at 30 °C for 30 minutes. After pre-incubation 2.0 ml overlay agar (45 °C) was added to each tube. The mixture was poured on minimal agar plates. After solidification the plates were incubated upside down for at least 48 hours at 37 °C in the dark.
EXPERIMENTAL PERFORMANCE
The following materials were mixed in a test tube and poured onto the selective agar plates:
100 µl test solution at each dose level, solvent (negative control) or reference mutagen solution (positive control)
500 µl S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test without metabolic activation)
100 µl Bacteria suspension (cf. test system, pre-culture of the strains)
2000 µl Overlay agar; the overlay agar contains per litre: 6.0 g MERCK Agar Agar; 6.0 g NaCl; 10.5 mg L-Histidine x HCl x H2O; 12.2 mg Biotin. Sterilisations were performed at 121 °C in an autoclave.
NUMBER OF REPLICATIONS: for each strain and dose level, including the controls three plates were used.
PRE-EXPERIMENT FOR TOXICITY
To evaluate the toxicity of the test item a pre-experiment was performed with strains TA 98 and TA 100. Eight concentrations were tested for toxicity and mutation induction with 3 plates each. The experimental conditions in the pre-experiment were the same as described for the main experiment I.
Toxicity of the test item results in a reduction in the number of spontaneous revertants or a clearing of the bacterial background lawn.
RAT LIVER S9
The S9 liver microsomal fraction was obtained from the livers of 8 - 12 weeks old male rats, strain Wistar Hanlbm (BRL, CH-4414 Füllinsdorf; weight approx. 220 - 320 g) which received three applications of 80 mg/kg b.w. Phenobarbital i.p. dissolved in aqua deionised (Desitin; D-22335 Hamburg) and β-Naphthoflavone orally dissolved in corn oil (Aldrich, D-89555 Steinheim). The livers were prepared 24 hours after the last treatment.
After decapitation of the anaesthetised animals the livers of the animals are removed, washed in 150 mM KCI and homogenised. The homogenate, diluted 1+3 in KCl, is centrifuged at 9000 g for 10 minutes at 4 °C.
Rat liver mix
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with 39 cofactor solution. The amount of S9 supernatant was 15 % vlv in the cultures. The concentrated cofactor solution yields the following concentrations in the S9 mix: 8 mM MgCl2, 33 mM KCI, 5 mM glucose-6-phosphate and 5 mM NADP in 100 mM sodium-ortho-phosphate-buffer, pH7.4.
During the experiment the S9 mix are stored in an ice bath. The S9 mix preparation is performed according to Ames et al.
HAMSTER LIVER S9
The S9 liver microsomal fraction was obtained from the liver of 7 - 8 weeks old male Syrian golden hamsters (BRL, CH-4414 Füllinsdorf).
After decapitation of the anaesthetised animals the livers of the animals were removed, washed in 0.1 M sodium phosphate buffer pH7.4,0.25 M sucrose and 1 mM disodium EDTA in deionised water and homogenised. The homogenate, diluted 1+3 in sodium phosphate buffer was centrifuged at 9000 g for 10 minutes at 4 °C.
A stock of the supernatants containing the microsomes was frozen in ampoules and stored at - 80 °C. Small numbers of the ampoules were kept at -20 °C for up to one week before use.
The protein content is determined using an analysis kit of Bio-Rad Laboratories, D-80939 München (Bio-Rad protein assay, Catalogue No. 5000006). The protein concentration in the S9 preparations was 32.5 (lot no. 110699) in the preexperiment and in experiment I (strains TA 98 and TA 100), 28.4 mglml, lot no 020999, (rat liver) in experiment I and 27.4 mglml, lot no. 270899 (hamster liver) in experiment II.
Hamster liver mix
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 cofactor solution. The amount of S9 supernatant is 30 % v/v. The concentrated cofactor solution yields the following concentrations in the S9 mix: 8.0 mM MgCl2, 33.0 mM KCI, 20 0 mM Glucose-6-phosphate, 2.8 units/ml Glucose-6-phosphate-dehydrogenase, 4.0 mM NADP, 2.0 mM NADH and 2.0 mM FMN in 100 mM Sodium-Ortho-Phosphate-buffer, pH7.4.
During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al. and Prival and Mitchell.
ACCEPTABILITY PF THE ASSAY
The Salmonella typhimurium reverse mutation assay is considered acceptable if it meets the following criteria:
- normal background growth in the negative and solvent control
- normal range of spontaneous reversion rates in the negative and solvent control
- the positive control substances should produce a significant increase in mutant colony frequencies - Evaluation criteria:
- A test item is considered positive if either a dose related increase in the number of revertants or a biologically relevant increase for at least one test concentration is induced.
A test item producing neither a dose related increase in the number of revertants nor a biologically relevant positive response at any one of the test points is considered non-mutagenic in this system.
A biologically relevant response is described as follows: a test item is considered mutagenic if the number of reversions is at least twice the spontaneous reversion rate in strains TA 98, TA 100, and TA 102 or thrice in strains TA 1535 and TA 1537.
Also, a dose-dependent and reproducible increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test item regardless whether the highest dose induced the criteria described above or not. - Species / strain:
- S. typhimurium, other: TA 1535, TA1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No relevant toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation up to the highest investigated dose.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with test substance at any concentration level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
POSITIVE CONTROL
Appropriate reference mutagens were used as positive controls. They showed a distinct increase in induced revertant colonies.
PRE-EXPERIMENT FOR TOXICITY
In the pre-experiment the concentration range of the test item was 3 - 5000 µg/plate. The preexperiment is reported as part of experiment I since no relevant toxic effects were observed and 5000 µg/plate were chosen as maximal concentration. - Conclusions:
- The test item was considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
- Executive summary:
The study was performed to investigate the potential of test item to induce gene mutations according to the plate incorporation assay with rat liver S9 (experiment I), and the pre-incubation test with hamster liver S9 (experiment II) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102. The assay was performed in two independent experiments, both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test item was tested at the following concentrations: 33, 100, 333, 1000, 2500 and 5000 µg/plate.
No relevant toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation up to the highest investigated dose.
The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used.
No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance.
Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Conclusion
During the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. Therefore, test item was considered to be non-mutagenic in this Salmonella typhimurium reverse mutation assay.
Reference
Summary of Results
S9 mix from: Hamster liver
S9 mix from: Rat liver
without S9 mix
Concentrationµg/plate | Revertants/plate mean from three plates | |||||||||
TA 1535 | TA 1537 | TA 98 | TA 100 | TA 102 | ||||||
I | II | I | II | I | II | I | II | I | II | |
Negative control | 14 | 13 | 14 | 20 | 18 | 22 | 101 | 115 | 220 | 289 |
Solvent control | 16 | 8 | 10 | 24 | 23 | 19 | 102 | 129 | 219 | 251 |
Positive control* | 1509 | 457 | 61 | 156 | 517 | 215 | 1424 | 949 | 1330 | 1091 |
33 | 18 | 12 | 15 | 27 | 17 | 21 | 104 | 125 | 232 | 352 |
100 | 20 | 13 | 14 | 16 | 20 | 29 | 117 | 121 | 221 | 376 |
333 | 18 | 12 | 13 | 21 | 23 | 23 | 116 | 132 | 229 | 358 |
1000 | 21 | 13 | 12 | 20 | 23 | 19 | 110 | 121 | 245 | 344 |
2500 | 16 | 11 | 18 | 24 | 23 | 22 | 102 | 147 | 233 | 272 |
5000 | 17 | 8 | 11 | 11 | 23 | 23 | 89 | 130 | 187 | 225 |
* Sodium azide (10.0 µg/plate) strains TA 1535 and TA 100; 4-nitro-o-phenylene-diarnine strains TA 1537 (50 µg/plate) and TA 98 (10.0 µg/plate); Methyl methane sulfonate (5 µg/plate) strain TA 102
with S9 mix
Concentrationµg/plate | Revertants/plate mean from three plates | |||||||||
TA 1535 | TA 1537 | TA 98 | TA 100 | TA 102 | ||||||
I | II | I | II | I | II | I | II | I | II | |
Negative control | 14 | 8 | 23 | 20 | 36 | 36 | 124 | 120 | 343 | 351 |
Solvent control | 13 | 8 | 17 | 23 | 34 | 29 | 119 | 133 | 316 | 376 |
Positive control** | 264 | 210 | 91 | 262 | 484 | 1811 | 674 | 942 | 1006 | 1237 |
33 | 9 | 8 | 16 | 18 | 29 | 30 | 118 | 113 | 336 | 326 |
100 | 12 | 10 | 18 | 25 | 28 | 40 | 99 | 140 | 320 | 411 |
333 | 13 | 10 | 17 | 26 | 33 | 32 | 101 | 168 | 343 | 401 |
1000 | 15 | 7 | 18 | 22 | 31 | 45 | 114 | 140 | 324 | 439 |
2500 | 8 | 7 | 17 | 24 | 30 | 40 | 97 | 159 | 313 | 411 |
5000 | 13 | 11 | 13 | 20 | 31 | 22 | 98 | 136 | 217 | 204 |
**2-arninoantlrracene (2.5 µg/plate) strains TA 1535, TA 1537 and TA 100; 2-aminoanthracene (10.0 µg/plate) strain TA 102 congo red (500 µg/plate) strain TA 98
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
There is no information about the in vitro gene mutation potential in bacteria of Reactive Red 147, thus the available information on the structural analogous Similar Substance 01 has been taken into consideration; the read across approach can be considered as appropriate and suitable to assess the property under investigation (details about the approach are reported into the IUCLID section 13).
The study was performed to investigate the potential of Similar Substance 01 to induce gene mutations according to the plate incorporation assay with rat liver S9 (experiment I) and the pre-incubation test with hamster liver S9 (experiment II), using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102. The assay was performed in two independent experiments, both with and without liver microsomal activation. The test item was tested at the following concentrations: 33, 100, 333, 1000, 2500 and 5000 µg/plate. No relevant toxic effects, evident as a reduction in the number of revertants, occurred in the test groups with and without metabolic activation up to the highest investigated dose. The plates incubated with the test item showed normal background growth up to 5000 µg/plate with and without S9 mix in all strains used. No substantial increase in revertant colony numbers of any of the five tester strains was observed following treatment with test item at any dose level, neither in the presence nor absence of metabolic activation (S9 mix). There was also no tendency of higher mutation rates with increasing concentrations in the range below the generally acknowledged border of biological relevance. Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
Therefore, during the described mutagenicity test and under the experimental conditions reported, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used and test item was considered to be non-mutagenic in the Salmonella typhimurium reverse mutation assay.
Justification for classification or non-classification
According to the CLP Regulation (EC ) No 1272/2008, for the purpose of the classification for germ cell mutagenicity, substances are allocated in one of two categories in consideration of the fact that they are:
- substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans or substances known to induce heritable mutations in the germ cells of humans or
- substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans.
The available information suggest that test substance did not show any reasons of concern from the genotoxicity point of view.
In conclusion, the substance does not meet the criteria to be classified for genetic toxicity according to the CLP Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.